U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07799077) titled 'Paclitaxel Polymeric Micelles and Cisplatin Plus Sintilimab as Neoadjuvant Therapy for Rese... Read More
U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07800559) titled 'The Combined Effect of Thoracic Manipulation and Instrument-assisted Soft Tissue Mobilizati... Read More
U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07799233) titled 'Dental-Oral and Craniofacial Characteristics of Hereditary Spastic Paraplegia: A Preliminar... Read More
U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07799363) titled 'Validation of Myocardial Perfusion and Extracellular Volume Assessment Using Photon-Countin... Read More
U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07799246) titled 'Brain and Blood Vessel Health Following Endometriosis Treatment in People With Endometriosi... Read More
U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07799922) titled 'IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus' on Aug. 28. Brief... Read More
Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Randomized, Operationally Seamless Phase 2/3 Study to Evaluate the Efficacy and Saf... Read More
Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Interventional Study of PF-08634404 in Combination with Chemotherapy in Participants wit... Read More
Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study Evaluating the Efficac... Read More
Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More